Peptide Agonists to Target GPCRs for Metabolic Disorders to Meet the Growing Patient Need

Time: 1:00 pm
day: Day Two AM

Details:

  • Lead optimization of a novel peptide agonist to target Class B GPCRs
  • Understanding the functionality of a novel peptide agonist by revealing the mechanisms of action and downstream signaling
  • Using structure-based insights to design high affinity and potent drugs

Speakers: